NCT06843239Phase 2Active not recruiting

Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)

Study sponsor: Zura Bio Inc

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-05Estimated
Enrollment · participants80Estimated
Source updated2026-07-20Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

· 1 field changed

Primary completion date changed

Before: Dec 2026. After: May 2027.

Check registry source